Cargando…
The splicing factor DHX38/PRP16 is required for ovarian clear cell carcinoma tumorigenesis, as revealed by a CRISPR‐Cas9 screen
Certain cancers, such as ovarian clear cell carcinoma (OCCC), display high levels of genetic variation between patients, making it difficult to develop effective therapies. In order to identify novel genes critical to OCCC growth, we carried out a comprehensive CRISPR‐Cas9 knockout screen against ce...
Autores principales: | Cona, Brandon, Hayashi, Tomoatsu, Yamada, Ai, Shimizu, Naomi, Yokota, Naoko, Nakato, Ryuichiro, Shirahige, Katsuhiko, Akiyama, Tetsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886329/ https://www.ncbi.nlm.nih.gov/pubmed/34965029 http://dx.doi.org/10.1002/2211-5463.13358 |
Ejemplares similares
-
CRISPR/Cas9 Screening for Identification of Genes Required for the Growth of Ovarian Clear Cell Carcinoma Cells
por: Kawabata, Ayako, et al.
Publicado: (2022) -
PHOSPHATE exporter XPR1/SLC53A1 is required for the tumorigenicity of epithelial ovarian cancer
por: Akasu‐Nagayoshi, Yoko, et al.
Publicado: (2022) -
Codependency and mutual exclusivity for gene community detection from sparse single-cell transcriptome data
por: Nakajima, Natsu, et al.
Publicado: (2021) -
Recent advances in ChIP-seq analysis: from quality management to whole-genome annotation
por: Nakato, Ryuichiro, et al.
Publicado: (2017) -
The HSF1–PARP13–PARP1 complex facilitates DNA repair and promotes mammary tumorigenesis
por: Fujimoto, Mitsuaki, et al.
Publicado: (2017)